Dividend Distribution Proposal 24-02-2023, 22:58

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as 2-11-2024, 02:00

Fox Announces Strategic Leadership Changes 10-02-2023, 09:35